The Dangers of Self-Administering More Frequently Without Medical Guidance Deviating from the prescribed once-weekly dosing without explicit, professional medical instruction carries significant risks: Dangerously High Drug Levels: Injecting semaglutide more frequently than prescribed, especially if the total weekly dose is inadvertently increased, can lead to dangerously high concentrations of the drug in your system
It is important to tell your allergist which product you are taking (including the manufacturer)
If you have a sensitive stomach, it is perfectly fine to take your zinc with a meal while keeping your glutathione dose separate
FDA concerns
Neither semaglutide nor tirzepatide currently appears on FDA's 503B bulks List or FDA's drug shortage list, largely foreclosing bulk compounding of essentially a copy of these agents by outsourcing facilities under Section 503B
Overweight and obesity are well-established Obesity is also associated with chronic low-grade inflammation, insulin resistance, and elevated levels of insulin-like growth factors, all of which can promote cancer development and progression
